- Organization Overview
- Dean’s Office
- Dean’s Office Overview
- PharmD Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Pharmacy Practice Partnerships
- Department of Bioengineering and Therapeutic Sciences
- Department of Clinical Pharmacy
- Department of Pharmaceutical Chemistry
- Quantitative Biosciences Institute
- Org Chart
- Patient Care
Burchard’s research highlighted in Newsweek
By UCSF School of Pharmacy Editorial Staff / Tue Nov 3, 2015
Esteban G. Burchard, MD, MPH, has been featured in Newsweek for his work studying genetic variation in asthma among minority populations. The article, titled “The Racial Discrimination Embedded in Modern Medicine,” was published online on October 20. It addresses issues such as racial health disparities, precision medicine, and the importance of including minorities in clinical research.
Researchers in the Burchard Lab—known as the Asthma Collaboratory—study the interplay between genes and their social and physical environments to determine the root causes of asthma health disparities. “His research shows that ethnicity is the most important factor in determining whether a patient will respond to asthma therapy—even more important than the severity of the disease or the patient’s socioeconomic status,” states Newsweek.
Burchard is a faculty member in the Department of Bioengineering and Therapeutic Sciences, a joint department of the UCSF Schools of Pharmacy and Medicine.
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.